|
2023 FIRST QUARTER OUTLOOK
RECONCILIATION OF GROSS MARGIN TO NON-GAAP GROSS MARGIN (Unaudited) | ||||||||
| Three Months Ending | ||||||||
| March 31, 2023 | ||||||||
| Low | High | |||||||
| Gross margin | 57.4 | % | 58.0 | % | ||||
| Adjustment to reconcile gross margin to non-GAAP gross margin: | ||||||||
| Stock-based compensation expense | 0.3 | % | 0.3 | % | ||||
| Non-GAAP gross margin | 57.7 | % | 58.3 | % | ||||
|
RECONCILIATION OF R&D AND SG&A EXPENSES TO NON-GAAP R&D AND SG&A EXPENSES
(Unaudited, in thousands) | ||||||||
| Three Months Ending | ||||||||
| March 31, 2023 | ||||||||
| Low | High | |||||||
| R&D and SG&A expenses | $ | 135,100 | $ | 139,100 | ||||
| Adjustments to reconcile R&D and SG&A expenses to non-GAAP R&D and SG&A expenses: | ||||||||
| Stock-based compensation expense | (39,000 | ) | (41,000 | ) | ||||
| Non-GAAP R&D and SG&A expenses | $ | 96,100 | $ | 98,100 | ||||
